Last reviewed · How we verify

NCT06065319

Wearables and Cardiac Rehabilitation

Active, enrolled Last updated 23 September 2024
What this trial tests

trial testing Wearable Sensors in Cardiac Rehabilitation in 18 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
1 October 2023
Primary endpoint
1 June 2024
1 October 2024

Quick facts

Lead sponsorTexas A&M University
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment18
Start date1 October 2023
Primary completion1 June 2024
Estimated completion1 October 2024
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Texas A&M University

Who can join

18 and older, any sex, with Cardiac Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to collect wearable sensor data that the investigators hypothesize will be useful in future algorithm development for monitoring recovering of participants enrolled in cardiac rehabilitation programs. Participants will be provided one or more smartwatches and/or smart rings to wear during a 14 week study which includes 2 weeks of baseline data collection and a 12-week, 36-session cardiac rehabilitation program. They will capture a pre-assessment 6 minute walk tests and a post-assessment 6 minute walk test. They will otherwise conduct standard cardiac rehabilitation program procedures and our sensors will capture data and sleep information throughout the study period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiac Rehabilitation

Currently open trials in the same condition.

Other Texas A&M University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06065319.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing